Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.94 PLN | -0.40% | -3.11% | -23.38% |
05-17 | Molecure S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-22 | Molecure S.A. Announces First Patient in the OATD-01 Phase 2 KITE Study in Pulmonary Sarcoidosis | CI |
- Stock Market
- Equities
- MOC Stock
- News Molecure S.A.
- MarketScreener Editorial Features